Inhibiting the VIM-2 Metallo-β-Lactamase by Graphene Oxide and Carbon Nanotubes

被引:22
|
作者
Huang, Po-Jung Jimmy [1 ]
Pautler, Rachel [1 ]
Shanmugaraj, Jenitta [1 ]
Labbe, Genevieve [1 ]
Liu, Juewen [1 ]
机构
[1] Univ Waterloo, Dept Chem, Waterloo Inst Nanotechnol, Waterloo, ON N2L 3G1, Canada
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
graphene; beta-lactamases; inhibition; adsorption; carbon nanotubes; nanomaterials; PSEUDOMONAS-AERUGINOSA; GOLD NANOPARTICLES; ENZYME-ACTIVITY; MEMBRANES;
D O I
10.1021/acsami.5b01954
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Metallo-beta-lactamases (MBLs) degrade a broad spectrum of antibiotics including the latest carbapenems. So far, limited success has been achieved in developing its inhibitors using small organic molecules. VIM-2 is one of the most studied and important MBLs. In this work, we screened 10 nanomaterials, covering a diverse range of surface properties including charge, hydrophobicity, and specific chemical bonding. Among these, graphene oxide and carbon nanotubes are the most potent inhibitors, while most other materials do not show much inhibition effect. The inhibition is noncompetitive and is attributed to the hydrophobic interaction with the enzyme. Adsorption of VIM-2 was further probed using protein displacement assays where it cannot displace or be displaced by bovine serum albumin (BSA). This information is useful for rational design inhibitors for MBLs and more specific inhibition might be achieved by further surface modifications on these nanocarbons.
引用
收藏
页码:9898 / 9903
页数:6
相关论文
共 50 条
  • [31] α-Aminophosphonate inhibitors of metallo-β-lactamases NDM-1 and VIM-2
    Palica, Katarzyna
    Deufel, Fritz
    Skagseth, Susann
    Metzler, Gabriela Paula Di Santo
    Thoma, Johannes
    Rasmussen, Anna Andersson
    Valkonen, Arto
    Sunnerhagen, Per
    Leiros, Hanna-Kirsti S.
    Andersson, Hanna
    Erdelyi, Mate
    RSC MEDICINAL CHEMISTRY, 2023, 14 (11): : 2277 - 2300
  • [32] cAbVIM4, a nanobody inhibiting the metallo-β lactamase VIM-4
    Sohier, J. -S.
    Pardon, E.
    Laurent, C.
    Lassaux, P.
    Buys, N.
    Willibal, K.
    Wyns, L.
    Steyaert, J.
    Galleni, M.
    FEBS JOURNAL, 2010, 277 : 241 - 241
  • [33] Nosocomial spread of Pseudomonas aeruginosa producing the metallo-β-lactamase VIM-2 in a Spanish hospital:: clinical and epidemiological implications
    Pena, C.
    Suarez, C.
    Tubau, F.
    Gutierrez, O.
    Dominguez, A.
    Oliver, A.
    Pujol, M.
    Gudiol, F.
    Ariza, J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (10) : 1026 - 1029
  • [34] VIM-12, a novel plasmid-mediated metallo-β-lactamase from Klebsiella pneumoniae that resembles a VIM-1/VIM-2 hybrid
    Pournaras, S
    Ikonomidis, A
    Tzouvelekis, LS
    Tokatlidou, D
    Spanakis, N
    Maniatis, AN
    Legakis, NJ
    Tsakris, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (12) : 5153 - 5156
  • [35] Nosocomial spread of Pseudomonas aeruginosa isolates expressing the metallo-β-lactamase VIM-2 in a hematology unit of a French Hospital
    Aubron, C
    Poirel, L
    Fortineau, N
    Nicolas, P
    Collet, L
    Nordmann, P
    MICROBIAL DRUG RESISTANCE, 2005, 11 (03) : 254 - 259
  • [36] First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-β-lactamase (VIM-2) in the United States
    Lolans, K
    Queenan, AM
    Bush, K
    Sahud, A
    Quinn, JP
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) : 3538 - 3540
  • [37] Nosocomial outbreak of imipenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo-β-lactamase in a kidney transplantation unit
    S Hammami
    I Boutiba-Ben Boubaker
    R Ghozzi
    M Saidani
    S Amine
    S Ben Redjeb
    Diagnostic Pathology, 6
  • [38] Molecular heterogeneity of blaVIM-2-containing integrons from Pseudomonas aeruginosa plasmids encoding the VIM-2 metallo-β-lactamase
    Pallecchi, L
    Riccio, ML
    Docquier, JD
    Fontana, R
    Rossolini, GM
    FEMS MICROBIOLOGY LETTERS, 2001, 195 (02) : 145 - 150
  • [39] Nosocomial outbreak of imipenem-resistant Pseudomonas aeruginosa producing VIM-2 metallo-β-lactamase in a kidney transplantation unit
    Hammami, S.
    Boutiba-Ben Boubaker, I.
    Ghozzi, R.
    Saidani, M.
    Amine, S.
    Ben Redjeb, S.
    DIAGNOSTIC PATHOLOGY, 2011, 6
  • [40] First outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa in The Netherlands: microbiology, epidemiology and clinical outcomes
    Van der Bij, A. K.
    Van Mansfeld, R.
    Peirano, G.
    Goessens, W. H. F.
    Severin, J. A.
    Pitout, J. D. D.
    Willems, R.
    Van Westreenen, M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 37 (06) : 513 - 518